The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
Gabelli Convertible and Income Securities Fund Inc
GCV · the NYSE · USD · Market cap $94M
The Gabelli Convertible and Income Securities Fund Inc.
FAIL · Does not pass the screenAt the last full screen
2026-06-14
Screened 2026-06-14 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Gabelli Convertible and Income Securities Fund Inc holds its Markdown at $4.66. The statistical read favours the buyers, held for 271 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 271 days |
| Price at the screen | $4.66 |
| Valuation | 4.61 trailing · N/A forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.79 |
Five Screens, Shown in Full
Does not pass. Financial sector: Financial
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Financial sector: Financial | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words| Trailing P/E | 4.6xvery cheap relative to earnings |
| EPS, trailing | 1.01 |
| Revenue growth | -39.8%revenue is shrinking |
| Profit margin | 1,016.1%highly profitable on every dollar of sales |
| Return on equity | 24.1%an exceptional return on shareholder capital |
| Dividend yield | 1,030.00% |
| Beta | 0.79steadier than the market |
| 52-week range | 3.67 - 4.77 |
| Moat | NONE |
| Market cap | $94M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGCV trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.58 | -0.4% | · | $996 | -0.4% |
| 2 months | $4.38 | +4.1% | · | $1,041 | +4.1% |
| 3 months | $4.19 | +8.8% | $0.12 | $1,117 | +11.7% |
| 6 months | $4.05 | +12.7% | $0.24 | $1,186 | +18.6% |
| 1 year | $3.39 | +34.5% | $0.48 | $1,487 | +48.7% |
| 2 years | $2.87 | +59.0% | $0.96 | $1,925 | +92.5% |
| 3 years | $3.07 | +48.6% | $1.44 | $1,956 | +95.6% |
| 5 years | $3.79 | +20.3% | $2.48 | $1,856 | +85.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GCV does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.